3001 - 3025 of 8142 Results
Title
Year
-
OPENTitle: Prescribing Aducanumab in the Face of Meager Efficacy and Real RisksJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 11Start Page: 545End Page: 547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452Best OA location URL: https://n.neurology.org/content/neurology/97/11/545.full.pdfCitation Count: 30
-
RESTRICTEDTitle: Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesisJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.816Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262606Citation Count: 1
-
OPENTitle: TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00200-yBest OA location URL: https://www.nature.com/articles/s41531-021-00200-y.pdfCitation Count: 4
-
OPENTitle: Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization studyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-93105-yBest OA location URL: https://www.nature.com/articles/s41598-021-93105-y.pdfCitation Count: 27
-
OPENTitle: Copy Number Variation in Parkinson's Disease: An Update from Sub‐Saharan AfricaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2442End Page: 2444Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28710Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530875Citation Count: 3
-
RESTRICTEDTitle: Plant immune system activation is necessary for efficient interaction with auxin secreting beneficial bacteriaJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17632/8zyrz7ccbh.1Citation Count: 0
-
RESTRICTEDTitle: Diagnostic accuracy of narrow‐band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: A systematic review and meta‐analysisJournal Name: Journal of Gastroenterology and HepatologyPublisher: WileyVol: 36Issue #: 10Start Page: 2659End Page: 2671Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/jgh.15577Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgh.15577Citation Count: 15
-
RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 1
-
OPENTitle: They Look but Do Not See—Gaze‐Evoked Eyelid SpasmJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1123End Page: 1125Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13279Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13279Citation Count: 0
-
RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Citation Count: 14
-
OPENTitle: Arousal characteristics in patients with Parkinson’s disease and isolated rapid eye movement sleep behavior disorderJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 44Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsab167Best OA location URL: https://academic.oup.com/sleep/article-pdf/44/12/zsab167/41608831/zsab167.pdfCitation Count: 6
-
RESTRICTEDTitle: Elevated Mood States in Patients With Parkinson’s Disease Treated With Deep Brain Stimulation: Diagnosis and Management StrategiesJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 33Issue #: 4Start Page: 314End Page: 320Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.20080205Citation Count: 9
-
OPENTitle: Lifestyle Factors and Parkinson’s Disease Risk in a Rural New England Case-Control StudyJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2021Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/5541760Best OA location URL: https://downloads.hindawi.com/journals/pd/2021/5541760.pdfCitation Count: 5
-
OPENTitle: SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00468-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00468-xCitation Count: 16
-
RESTRICTEDTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 31
-
OPENTitle: Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 109333End Page: 109333Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.109333Best OA location URL: http://www.cell.com/article/S2211124721007099/pdfCitation Count: 32
-
RESTRICTEDTitle: Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein PathologyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1487End Page: 1488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28618Citation Count: 4
-
RESTRICTEDTitle: Coexistence of deep brain stimulators and cardiac implantable electronic devices: A systematic review of safetyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 88Issue #:Start Page: 129End Page: 135Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.018Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A3638884/viewCitation Count: 2
-
OPENTitle: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 7Start Page: 781End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-021-00826-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-021-00826-9.pdfCitation Count: 14
-
OPENTitle: Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1733End Page: 1733Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28659Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28659Citation Count: 1
-
RESTRICTEDTitle: Managing Advanced Parkinson DiseaseJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 34Issue #: 4Start Page: 289End Page: 300Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/08919887211018277Citation Count: 6
-
RESTRICTEDTitle: Parkinson disease-associated cognitive impairmentJournal Name: Nature Reviews Disease PrimersPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41572-021-00280-3Best OA location URL: https://www.nature.com/articles/s41572-021-00280-3.pdfCitation Count: 392
-
RESTRICTEDTitle: Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participantsJournal Name: BMJ OpenPublisher: BMJVol: 11Issue #: 7Start Page: e046329End Page: e046329Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2020-046329Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/11/7/e046329.full.pdfCitation Count: 18
-
RESTRICTEDTitle: Progress towards therapies for disease modification in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 559End Page: 572Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00061-2Best OA location URL: https://discovery.ucl.ac.uk/10130306/1/Foltynie_Disease%20Modifying%20reviewVersion4_ML2_CLEAN.pdfCitation Count: 157
-
RESTRICTEDTitle: Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of viewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 88Issue #:Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.013Citation Count: 16